Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Ocular Manifestations in MPGN (C3 Dense Deposit Disease) on the island of Ireland
Author Affiliations & Notes
  • Laura Nicole Cushley
    Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom
  • Clara McAvoy
    Department of Ophthalmology, HCS Belfast Health and Social Care Trust, Belfast, United Kingdom
  • Neal Morgan
    Nephrology, Beaumont Hospital, Dublin, Ireland
    Nephrology, Southern Health and Social Care Trust, Portadown, United Kingdom
  • Anthony Dorman
    Pathology, Beaumont Hospital, Dublin, Dublin, Ireland
  • Tunde Peto
    Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom
    Department of Ophthalmology, HCS Belfast Health and Social Care Trust, Belfast, United Kingdom
  • Vittorio Silvestri
    Department of Ophthalmology, HCS Belfast Health and Social Care Trust, Belfast, United Kingdom
  • Peter Maxwell
    Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom
  • Mairead Convery
    Paediatric Nephrology, HCS Belfast Health and Social Care Trust, Belfast, United Kingdom
  • Peter J Conlon
    Nephrology, Beaumont Hospital, Dublin, Ireland
  • Julie Silvestri
    Department of Ophthalmology, HCS Belfast Health and Social Care Trust, Belfast, United Kingdom
  • Footnotes
    Commercial Relationships   Laura Cushley None; Clara McAvoy Roche, Code C (Consultant/Contractor), Alimera, Code R (Recipient); Neal Morgan None; Anthony Dorman None; Tunde Peto Alimera, Abbvie, Bayer, Roche, Novartis, Heidelberg, Zeiss, Optos, Optomed, Oxurion, B-I, Code C (Consultant/Contractor), B-I, Roche, Code F (Financial Support); Vittorio Silvestri None; Peter Maxwell None; Mairead Convery None; Peter J Conlon None; Julie Silvestri Roche, Bayer, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 798. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Laura Nicole Cushley, Clara McAvoy, Neal Morgan, Anthony Dorman, Tunde Peto, Vittorio Silvestri, Peter Maxwell, Mairead Convery, Peter J Conlon, Julie Silvestri; Ocular Manifestations in MPGN (C3 Dense Deposit Disease) on the island of Ireland. Invest. Ophthalmol. Vis. Sci. 2024;65(7):798.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the retinal features of membranoproliferative glomerulonephritis (MPGN) C3 Dense Deposit Disease (DDD) in a cohort of patients on the Island of Ireland and to correlate this with age of onset of retinal findings

Methods : Thirty-six individuals were identified as having MPGN C3 DDD from renal clinics in Belfast and Dublin, 21 from Northern Ireland and 15 from Republic of Ireland. Each individual had a full ophthalmic assessment, review of the histopathological diagnosis, colour retinal imaging (a subset also had OCT) and had a venous sample taken for genotyping. Retinal images were graded by the Belfast Ophthalmic Reading Centre and a consultant ophthalmologist. Drusen were graded as hard distinct, soft distinct, soft indistinct and reticular within the regions. All data were collated into an excel spreadsheet and statistical analysis was conducted.

Results : Of the 36, 28 (77.8%) had retinal images and 6 (16.7%) had OCT. The mean age was 67.6 years, and the average age of onset was 17 years. There were 23 females (63.9%) and 13 males (36.1%). Some, 25% had had more than 1 renal transplant. Only 2 described visual symptoms.

Nearly all, 98% showed various degrees of RPE atrophy and 100% of individuals showed disease involvement in the macular region. A majority, 68% showed one or more categories of drusen with 44% showing soft indistinct drusen. The most common type of distribution was in the temporal macular area with the drusen being distributed in a cone shape in the temporal macula. (34%). Only 9% of individuals showed evidence of fibrosis. In addition, 42% showed pigmentary changes. On OCT, 27% of all cases had an epi-retinal membrane, of these 56% lacked the presence of drusen.

Conclusions : All individuals with MPGN C3 DDD had some degree of retinal involvement. Generalised atrophy of the RPE is the most common finding. The majority of cases have shown lipoid depositions in the form of soft indistinct drusen which were distributed in a cone-like configuration towards the temporal end of the macula. However other features such as fibrosis and pigmentary changes have been observed at a relatively lower percentage. Following analysis of the retinal findings we propose the following grading for MPGN C3 DDD retinopathy (Table 1).

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×